Supplier info centre > Related news headlines
All news headlines forJohnson MattheySee also : Supplier info centre | All products for Johnson Matthey |
 |
Smopex scavenges for metal
22-Feb-2007 - Johnson Matthey's metal scavenging system, Smopex, is designed to remove precious metals at high speed from solutions and active pharmaceutical ingredients (APIs).
Adderall drives pharma division at Johnson Matthey
30-Jan-2007 - Johnson Matthey has announced a reassuring business update ahead of its 31 March year-end, suggesting that Adderall is the driving force behind a recovery in its pharmaceutical materials business.
Pfizer outsources API manufacture to Asia
17-Oct-2006 - Pfizer CentreSource has decided to outsource the manufacture of some of its active pharmaceutical ingredients (API) to two Asian contract manufacturers and intends to work with the Food and Drug Administration's (FDA) during the process.
Excelsyn chases process improvement
16-Oct-2006 - Excelsyn Molecular Development claims to have made a "major advance" in a protein intensification process that can be used to slash the manufacturing costs of a range of amino acids.
Date set for major outsourcing conference
25-May-2006 - Registration is now open for the annual "Pharmaceutical Outsourcing of Discovery Chemistry, Advanced Intermediates and API's" conference, which this year celebrates its 10th anniversary.
Matthey buys Davy from Yukos for $71m
13-Feb-2006 - Johnson Matthey, a British catalyst, precious metals and chemicals firm with a division that provides contract manufacturing services of active pharmaceutical ingredients (APIs) to pharmaceutical companies, has bought chemical technology licence specialist Davy Process Technology from troubled former oil giant Yukos for $71m (€60m) in cash, allowing it to expand...